Masimo (MASI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$179.950.00%
Close 2026-06-10 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · MASI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 55.7% |
| Our one-year growth estimate | diamond | 0.1% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 55.7 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 43 industry peers · Company calendar date is not available
MASI — director departure
Dated 2026-06-10
Catherine Szyman, Gregory Meehan, Charles Dadswell: Executives resigned their employment and board positions in connection with a Merger.
Why it matters: Masimo expects the merger to close in 2026. Closing would complete the announced $180-per-share cash deal.
Supportive ifA company filing or press release confirms the merger closed by December 31, 2026, with $180 cash per share.
Worry ifThe merger has not closed by December 31, 2026. Or a filing reports that it ended or a closing condition failed.
Why it matters: Masimo's stated 2026 revenue guide points to 9% growth. Reaching it would show progress on a repeated company priority.
Supportive ifReported 2026 revenue is at or above $1.523 billion.
Worry ifReported 2026 revenue is below $1.523 billion, or the company cuts its 2026 revenue guide.
Why it matters: Gross profit rose only modestly from the prior quarter. Another increase would show the company is still making progress on margins.
Supportive ifA later quarter reports gross profit above $250.8 million.
Worry ifA later quarter reports gross profit at or below $250.8 million.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$8 on $10,000 · ±0.1% | How much price usually moves either way. |
| Bad day | $222 loss on $10,000 · 2.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,712 loss on $10,000 · 17.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.